findmyKOL
Clinical trialNCT01303796CompletedPhase 3Interventional

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

SponsorCyclacel Pharmaceuticals, Inc.Enrollment482Acute Myeloid Leukemia
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

118 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Austria
  • Medizinische Universitaetsklinik

    Innsbruck, Austria

  • Elisabethinen Krankenhaus

    Linz, Austria

  • Krankenhaus Der Barmherzigen Schwestern

    Linz, Austria

  • Univ. Klinik Fur Innere Medizin Iii Lkh

    Salzburg, Austria

  • Akh Wien

    Vienna, Austria

  • Hanusch Krankenhaus

    Vienna, Austria

  • Klinikum Wels-Grieskirchen Gmbh

    Wels, Austria

Belgium
  • Ziekenhuis Netwerk Antwerpen Stuivenberg

    Antwerp, Belgium

  • Az Sint-Jan Brugge-Oostende

    Bruges, Belgium

  • Universite Catholique de Louvain

    Brussels, Belgium

  • Centre Hospitalier de Jolimont-Lobbes

    La Louvière, Belgium

  • Cliniques Universitaires Ucl de Mont-Godinne

    Yvoir, Belgium

France
  • Chu D'Amiens Hopital Sud

    Amiens, France

  • Centre Hospitalier de la Cote Basque

    Bayonne, France

  • Chu de Lyon - Hopital Edouard Herriot

    Lyon, France

  • Institut Paoli Calmettes

    Marseille, France

  • Chru de Montpellier Hopital St. Eloi

    Montpellier, France

  • Centre Hospitalier de Mulhouse

    Mulhouse, France

  • Hopital St Louis Universite Paris 7

    Paris, France

  • Centre Hospitalier D'Annecy

    Pringy, France

  • Centre Hospitalier de Perigueux

    Périgueux, France

  • Centre Hospitalier de Saint-Brieuc Yves Ie Foll

    Saint-Brieuc, France

  • Chu de Strasbourg - Hopital Civil

    Strasbourg, France

  • Strasbourg Oncologie Liberale

    Strasbourg, France

  • Chu de Tours Hopital Bretonneau

    Tours, France

Germany
  • Universitaetsklinikum Charite Berlin, Campus Benjamin Franklin

    Berlin, Germany

  • Universitaetsklinikum Carl-Gustav-Carus Dresden

    Dresden, Germany

  • St. Johannes Hospital

    Duisburg, Germany

  • Klinikum Frankfurt Hoechst

    Frankfurt, Germany

  • Asklepios Klinik Altona

    Hamburg, Germany

  • Medizinische Hochschule Hannover

    Hanover, Germany

  • Slk Kliniken Heilbronn

    Heilbronn, Germany

  • Klinikum St. Georg

    Leipzig, Germany

  • Johannes Wesling Klinikum

    Minden, Germany

  • Tu Muenchen

    München, Germany

  • Universitaetsklinikum Muenster

    Münster, Germany

Hungary
  • University of Debrecen

    Debrecen, Hungary

  • Petz Aladar Megyei Oktato Korhaz

    Győr, Hungary

  • Kaposi Mor Oktato Korhaz

    Kaposvár, Hungary

Italy
  • Aou Ospedali Riuniti Umberto I

    Ancona, Italy

78 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

DecitabineSapacitabine
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 Oct 2011
Primary completion
15 Dec 2016
Completion
31 Jul 2017
Last update posted
22 Jun 2022
Registered enrollment
482
Registry id
NCT01303796

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.